Identification and characterization of in silico, in vivo, in vitro, and reactive metabolites of infigratinib using LC-ITMS: bioactivation pathway elucidation and in silico toxicity studies of its metabolites
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.